Nebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of age

Basit Öğe Kaydı
dc.authorid8752en_US
dc.authorid132370en_US
dc.authorid132303en_US
dc.authorid110112en_US
dc.authorid9608en_US
dc.contributor.authorErdil, Nevzat
dc.contributor.authorKaynak, Murat
dc.contributor.authorDönmez, Köksal
dc.contributor.authorDişli, Olcay Murat
dc.contributor.authorBattaloğlu, Bektaş
dc.date.accessioned2017-07-18T08:59:30Z
dc.date.available2017-07-18T08:59:30Z
dc.date.issued2014
dc.departmentİnönü Üniversitesien_US
dc.descriptionRev Bras Cir Cardiovasc 2014;29(4):581-7en_US
dc.description.abstractObjective: Postoperative atrial fibrillation is a common complication after cardiac surgery, with an incidence as high as 20-50%. Increased age is associated with a significant increase in postoperative atrial fibrillation risk. This common complication is associated with higher morbidity and mortality rates. The aim of this study was to assess the efficacy of nebivolol in preventing atrial fibrillation following coronary artery bypass surgery in patients over 60 years of age. Methods: In this prospective randomized study, 200 patients who were candidates for elective coronary artery bypass surgery were divided into two groups. The first group was administered with nebivolol and the second group was administered with metoprolol. Treatment was initiated four days prior to surgery, and patients were monitored for atrial fibrillation until discharge. Forty-one patients recieved 50 mg metoprolol succinate daily, which was initiated minimum 4 days before surgery. Results: Demographic data were similar in both groups. The incidence of postoperative atrial fibrillation in both groups was similar, with no significant difference being identified [n=20 (20%); n=18 (18%), P=0.718; respectively]. There were not any mortality at both groups during study. Inotropic agent requirement at ICU was similar for both groups [n=12 (12%), n=18 (18%), P=0.32]. Conclusion: We compared the effectiveness of nebivolol and metoprolol in decreasing the incidence of postoperative atrial fibrillation, and determined that nebivolol was as effective as metoprolol in preventing postoperative atrial fibrillation at patients. Nebivolol may be the drug of choice due to its effects, especially after elective coronary artery bypass surgery.en_US
dc.identifier.citationERDİL, N., KAYNAK, M., DÖNMEZ, K., DİŞLİ, O. M., & BATTALOĞLU, B. (2014). Nebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of age. REVISTA BRASILEIRA DE CIRURGIA CARDIOVASCULAR , 0–0.en_US
dc.identifier.endpage0en_US
dc.identifier.issue0en_US
dc.identifier.startpage0en_US
dc.identifier.urihttps://www.ncbi.nlm.nih.gov/pmc/articles/PMC4408822/pdf/rbccv-29-04-0581.pdf
dc.identifier.urihttps://hdl.handle.net/11616/7402
dc.identifier.volume0en_US
dc.language.isoenen_US
dc.publisherRevısta Brasıleıra De Cırurgıa Cardıovascularen_US
dc.relation.ispartofRevısta Brasıleıra De Cırurgıa Cardıovascularen_US
dc.rightsinfo:eu-repo/semantics/openAccessen_US
dc.subjectCoronary artery bypassen_US
dc.subjectAtrial Fibrillationen_US
dc.subjectAnti-Arrhythmia Agentsen_US
dc.subjectDrug Therapyen_US
dc.titleNebivolol in preventing atrial fibrillation following coronary surgery in patients over 60 years of ageen_US
dc.typeArticleen_US

Dosyalar

Orijinal paket
Listeleniyor 1 - 1 / 1
Küçük Resim
İsim:
Makale Dosyası.pdf
Boyut:
326.34 KB
Biçim:
Adobe Portable Document Format
Açıklama:
Makale Dosyası
İndir
Lisans paketi
Listeleniyor 1 - 1 / 1
Küçük Resim Yok
İsim:
license.txt
Boyut:
1.71 KB
Biçim:
Item-specific license agreed upon to submission
Açıklama:
İndir

Koleksiyon

Tıp Fakültesi, Kalp ve Damar Cerrahisi Anabilim Dalı Koleksiyonu